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Background: Previous human exposure studies of traffic-related air pollutants have demonstrated adverse
health effects in human populations by comparing areas of high and low traffic, but few studies have utilized
microenvironmental monitoring of pollutants at multiple traffic locations while looking at a vast array of health
endpoints in the same population. We evaluated inflammatory markers, heart rate variability (HRV), blood
pressure, exhaled nitric oxide, and lung function in healthy participants after exposures to varying mixtures of
traffic pollutants.
Methods: A repeated-measures, crossover study design was used in which 23 healthy, non-smoking adults had
clinical cardiopulmonary and systemic inflammatory measurements taken prior to, immediately after, and 24 hours
after intermittent walking for two hours in the summer months along three diverse roadways having unique
emission characteristics. Measurements of PM2.5, PM10, black carbon (BC), elemental carbon (EC), and organic
carbon (OC) were collected. Mixed effect models were used to assess changes in health effects associated with
these specific pollutant classes.
Results: Minimal associations were observed with lung function measurements and the pollutants measured.
Small decreases in BP measurements and rMSSD, and increases in IL-1β and the low frequency to high frequency
ratio measured in HRV, were observed with increasing concentrations of PM2.5 EC.
Conclusions: Small, acute changes in cardiovascular and inflammation-related effects of microenvironmental
exposures to traffic-related air pollution were observed in a group of healthy young adults. The associations were
most profound with the diesel-source EC.
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Due to population growth, the expansion of metropol-
itan areas, and the increasing dependence upon motor
vehicles, the fraction of the population residing or work-
ing near major roadways has increased, representing a
potentially vulnerable population of individuals experi-
encing adverse health effects related to the inhalation of
traffic-related air pollution. In epidemiological studies,
exposures to traffic pollutants have been associated with* Correspondence: Terry.Gordon@nyumc.org
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this article, unless otherwise stated.acute and chronic respiratory morbidity [1–3], cardio-
vascular morbidity [4, 5], and all-cause mortality [6, 7].
In order to better understand the underlying mecha-
nisms involved in these associations researchers have
started conducting field panel studies that can allow for
more extensive biological monitoring and improved
pollutant characterization (i.e., personal or microenvi-
ronmental monitoring) to assess the source-related air
pollution components responsible for any measured
adverse health effects. The results of many field panel
studies have uncovered associations between specific
traffic pollutants and changes in blood pressure (BP) [8],
heart rate variability (HRV) [9], lung function [10], andticle is distributed under the terms of the Creative Commons Attribution
mons.org/licenses/by/4.0/), which permits unrestricted use, distribution,
you give appropriate credit to the original author(s) and the source,
ense, and indicate if changes were made. The Creative Commons Public
ommons.org/publicdomain/zero/1.0/) applies to the data made available in
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either failed to find associations with these health effects
or found only minor associations [12, 13]. This could
be due to differences in the population demographics
and/or measured pollutant components across studies.
Thus, we undertook a new study in which we conducted
detailed exposure assessment monitoring as well as a
vast array of health endpoints measured in the same
population during exposures to different complex air
pollution mixtures.
Recent improvements in technology have allowed re-
searchers to collect personal exposures of air pollutants
more easily in a field setting. However, due to a lack of
access to an electricity supply, or a place safe enough to
carry out medical procedures, it remains difficult to col-
lect as many health measurements in the field compared
to a clinical setting. This inability to collect certain
health measurements in an ambient setting hampers the
ability of researchers to measure transient health effects
following pollutant exposures. In this work, we ad-
dressed this limitation by using a novel application of
dried blood spots (DBS) to gather blood from subjects in
the field. This method is minimally invasive, easily per-
formed in the field, requires little previous training to
administer, and samples can be collected quickly and re-
petitively [14–16]. By relying on DBS, the present study
extends the previous literature of measuring short-term
adverse health effects associated with microenvironmen-
tal exposures to traffic-related air pollutants.
We measured a variety of health-related effects in
adults before and after walking alongside three public
roadways with diverse vehicle types and traffic volumes,
providing a more complete range of pollutant concentra-
tions compared to past studies. The health measure-
ments studied in this work have previously been used to
demonstrate negative impacts of exposures to traffic
pollutants and span multiple biological systems (i.e., car-
diovascular, respiratory, and immune), providing a large
overview of how toxic pollutants may elicit subclinical
health effects in a human population. We used DBS to
safely collect blood samples from our subjects away from
a medical office to look at acute and lasting changes in
blood cytokines related to inflammation. We hypothe-
sized that acute exposure to traffic pollutants would in-




During the months of June through September of 2011
and 2012, healthy adult participants, aged 18–40 years,
were recruited from the Northern New Jersey - Southern
New York area via personal contacts and flyers. To
minimize risks associated with mild exercise and/or airpollution exposure, participants were excluded if they:
1) did not think they could maintain the required exer-
cise level and duration; and 2) reported tobacco use,
asthma or other respiratory disease, type 2 diabetes, or
cardiovascular disease. Participants were asked to refrain
from consuming caffeine after midnight prior to all ex-
posures. All participants provided written consent, ap-
proved by New York University’s School of Medicine’s
Institutional Review Board, prior to enrollment.
Study design
We conducted a randomized crossover study of similar
exposure sessions at three locations that were in proxim-
ity to roadways with different traffic types but similarly
affected by the long- range transport of regional air
pollutants. Participants met an investigator prior to each
exposure at a designated area within walking distance
from the pre-selected exposure roadways for pre-
exposure measurements (i.e., a different field setting was
used for each location). Once the pre-exposure data col-
lection was completed, each participant walked at a
moderate pace (approximately 3 mph) for approximately
2 h on nearly level ground, alternating between 20 min
of walking and 5 min of rest. At each location, a pedom-
eter was worn by the study investigator.
Microenvironmental pollution measurements were
collected while participants were walking. Immediately
and 24 h following each exposure, the participants
underwent another series of health measurements. Post-
exposure health measurements were collected at the
same designated field settings as the pre-exposure mea-
surements. Twenty-four hours after each exposure,
health measurements were taken at a field location near
the home or workplace of each subject to minimize add-
itional traffic exposures to each subject. All exposure
sessions were separated by at least 2 weeks, and were
generally confined to the same weekday; participants
were permitted to substitute among Tuesday, Wednesday,
and Thursday exposures. Between 1 and 5 participants
completed each exposure session simultaneously.
Study locations
The locations chosen for this study included the George
Washington Bridge (GWB), the Garden State Parkway
(GSP), and a lightly travelled rural road in Sterling
Forest (SF), which straddles the border between NJ and
NY. The upper deck of the George Washington Bridge
connects Northern New Jersey and Northern Manhattan,
and has eight traffic lanes open to trucks, buses, and auto-
mobiles. A pedestrian walkway is located directly adjacent
to the southern side of the upper deck. The GSP is re-
stricted to only automobiles, limiting exposure to diesel
engine exhaust. At this location, a sidewalk in a residential
area located 30 m from the roadway in Nutley, New Jersey
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State Park in New York and has limited traffic.
Exposure assessment
Particulate matter (PM) samples were collected using a
custom-built mobile sampling platform [17] that col-
lected samples alongside the subjects during their expo-
sures. PM10 was sampled using an Aerotec-2 cyclone as
a pre-collector of oversized particles at a total flow rate
of 171 l per minute (LPM) [18], which was divided
between a 37 mm Teflon filter (Pall Corporation, Ann
Arbor, MI) and 37 mm quartz filter (Pall). Two add-
itional inlet cyclones limited the sampling to PM2.5 at 25
LPM [18], also divided between the 2 filter types. Teflon
filters were conditioned and weighed (XS105, Mettler-
Toledo Inc., Highstown, NJ) in an environmentally con-
trolled weighing facility for a minimum of 24 h before
and after use. Elemental carbon (EC) and organic carbon
(OC) were analyzed according to NIOSH Method 5040
(Lab ECOC Aerosol Analyzer, Sunset Instruments Inc.,
Hillsborough, NC).
A continuously-monitoring, real-time micro-Aethalometer
(microAeth model AE51, Magee Scientific, Berkeley,
CA) measured black carbon (BC) every minute at a
flow of 150 mL/min. A continuous gas analyzer logged
measurements of carbon monoxide (CO), nitric oxide
(NO), nitrogen dioxide (NO2), sulfur dioxide (SO2), and
ozone (O3) concentrations (Advanced Sense Analyzer,
GrayWolf Sensing Solutions, Shelton, CT) at 1-min
intervals.
Ambient hourly O3 concentrations were obtained from
the United States Environmental Protection Agency’s Air
Quality System Data Mart (http://www.epa.gov/airquality/
airdata/). For each location, the closest central monitor col-
lecting O3 concentrations was determined, and the selected
central monitor was located no further than 10 miles away
from each location. Average O3 concentrations were calcu-
lated between 7 am and 12 pm the day of each exposure.
Hourly relative humidity (RH) and ambient tem-
perature measurements were obtained from the New
Jersey Department of Environmental Protection’s Air
Quality Index Now reports for the East Orange location
(http://www.njaqinow.net/Default.ltr.aspx). Noise mea-
surements were taken at the various locations for a se-
lect number of exposures in the summer of 2012. At SF,
1 measurement was taken, while 2 measurements were
taken at the GSP and 4 measurements were taken at the
GWB. For these exposures, A-weighted noise levels were
measured during the four 5 min rest periods and aver-
aged (Radioshack, Sound Level Meter). A-weighted noise
levels, as suggested by the Occupational Safety and
Health Administration, relates to the human perception
of loudness by the human ear and is measured on a
logarithmic scale [19].Traffic volume data for the GSP were obtained for the
Essex Toll Plaza using the New Jersey Turnpike Authority’s
Open Public Records Act. Traffic volume data at the GWB
were obtained for the GWB upper level and Palisades
Interstate Parkway tolls from the Port Authority of New
York and New Jersey (PANYNJ). Virtually no traffic was
observed at SF, as verified by study staff during exposures.Health measurements
Health measurements were collected before, immedi-
ately after, and 24 h following each exposure. The order
of the endpoints (exhaled nitric oxide (eNO), HRV, lung
function, BP, and blood prick) was kept consistent.
eNO was measured using a NIOX MINO (Aerocrine
AB, Stockholm, Sweden) according to American Thoracic
Society’s (ATS) recommendations [20], with the exception
that a single measurement was taken at each time point.
Lung function parameters (forced vital capacity [FVC] and
forced expiratory volume in the first second [FEV1]) were
measured using a portable spirometer (KoKo Legend,
Ferraris Respiratory, Colorado) according to ATS criteria
[21]; the subjects were seated, did not wear a nose clip, and
the same investigator provided all coaching. Once 3 accept-
able readings were recorded, the maximum values were
used for analysis.
A digital electrocardiogram (ECG) recording of each
subject was acquired continuously for 24 h using a 3-lead
Holter monitor (Cardio Data Systems, East Syracuse, NY).
At each of the 3 measurement time points, the participant
rested for 15 min, and the last 5 min were used for
the analysis (Impressario, Version 3.07.0158, Spacelab,
Washington). The ECG tracings were manually inspected
to correct for mislabeled beats. Time- and frequency-
domain indices of the standard deviation of the NN inter-
vals (SDNN), root mean squared of successive deviations
in NN intervals (rMSSD), high frequency (HF) (0.15-
0.40 Hz), low frequency (LF) (0.04-0.15 Hz), LF:HF, and
heart rate (HR) were obtained.
Single systolic BP (SBP) and diastolic (DBP) measure-
ments were obtained using an automated BP monitor
(Omron HEM-705CP, Omron Healthcare, Inc, Japan) at
each time point. Pulse pressure (PP) was calculated by
subtracting the DBP measurements from the SBP mea-
surements. Mean arterial pressure (MAP) was calculated
as: DBPþ 13 SBP‐DBPð Þ.
Biomarkers of inflammation were measured from ca-
pillary whole blood collected on a neonatal Guthrie card
(903® Protein Saver Card, Whatman, Westborough,
MA). An area of the finger was swabbed with an alcohol
pad, dried, and pricked with a lancet. Blood drops were
applied to the collection area until full. The DBS were
allowed to dry at ambient temperature away from sun-
light, and then placed in a gas-impermeable plastic bag
Table 1 Subject characteristics
All subjects 23
Gender
Male 11 (48 %)
Female 12 (52 %)
Age (years) 25 (18–33)
Weight (lbs) 162 (116–270)
Body mass index 25 (20–39)
Race/ethnicity
White 17 (74 %)
Black 1 (4 %)
Asian 2 (9 %)
Hispanic 2 (9 %)
Other 1 (4 %)
Past smoker 2 (9 %)
Smoker at home 0 (0 %)
Values are represented as either mean (range) or mean (%) for 23 subjects
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for each subject at each time point.
Blood samples were punched from each DBS and
placed into individual wells of a 96 deep-well plate (USA
Scientific, Ocala, FL). 200 μL of phosphate buffered sa-
line (Sigma-Aldrich, St. Louis, MO) with 0.5 % Tween
20 (Sigma-Aldrich) were added to each well, completely
submerging each sample. The plate was covered, cooled,
and continuously shaken overnight (Model DS1, IKA
Works). The following day, sample eluents were ana-
lyzed for protein content (C-reactive protein (CRP),
serum amyloid A (SAA), soluble intercellular adhesion
molecule (sICAM), soluble vascular adhesion molecule
(sVCAM), interleukin 1-beta (IL-1β), interleukin-6
(IL-6), interleukin-8 (IL-8), and tumor necrosis factor-
alpha (TNF-α)) using Meso Scale Discovery (SECTOR®
Imager 2400, Meso Scale Diagnostics, Gaithersburg, MD).
Cortisol was measured using a commercially available kit
(R&D Systems, Minneapolis, MN), where absorption was
measured with a microplate reader at 450 nm (Ceres UV
900 HDi, Bio-Tek Instruments, Winooski, VT). All samples
were run in singlets.
Statistical analysis
Exposure data were analyzed for differences across lo-
cations using an analysis of variance (ANOVA)
followed by a Student Newman-Keul’s post hoc test,
or, where applicable, an unpaired t-test, in Prism 5.0
for Windows (GraphPad Software, San Diego, CA).
Repeated-measures ANOVA was used to assess for statis-
tical differences among pre-exposure health values at the
3 exposure sites. The health outcomes for each observa-
tion were then analyzed as a percent change between the
pre-exposure measurement and each subsequent meas-
urement (i.e., post or 24 h post) using repeated-measures
ANOVA followed by a Student Newman-Keul’s post hoc
test. Then, the percent change of health outcomes was
associated with each air quality index in a mixed effects
model with a random subject intercept, fixed indicators
for location, and fixed linear effects for apparent
temperature and the exposure of interest using the lme4
package version 1.1-7 in R (R Foundation for Statistical
Computing, Vienna, Austria) version 3.1.1. The fixed
indicator for location was used to address any possible
influences due to the location independent of air pollu-
tion. To test whether differences in test location should
be included in the model, a separate mixed effect
model with location removed, was also run. The results
from this model showed decreases in the magnitude of
the point estimates, suggesting that differences in loca-
tion could be influencing the health effects measured.
Therefore, we chose to include location in our model
to assess changes in health outcomes solely due to the
air pollution metrics measured. Apparent temperaturewas calculated using a formula [22] which takes into
account ambient temperature and relative humidity.Results
Participant characteristics
Thirty-six volunteers were recruited for this study; 2 par-
ticipants were excluded due to smoking status and 8
participants were not available to participate during our
time frame. Of the remaining 26 subjects, 21 partici-
pants completed 3 exposures, 2 subjects completed 2 ex-
posures, and 3 subjects completed only 1 exposure. The
characteristics of the subjects can be found in Table 1,
and the pre-exposure values of the biological endpoints
are shown in Table 2. Little variability existed among the
pre-exposure values at the 3 locations, with the excep-
tion of SAA and CRP in which statistically significant
pre-exposure values were elevated at GWB compared to
SF and GSP (Table 2).Exposure assessment measurements
In total, SF was utilized 15 times, GSP 14 times, and
GWB 9 times over the 2 summer exposure periods. No
statistically significant differences were observed for the
driving distance between the exposure sites and the
homes of each participant, the walking pace during ex-
posures, and the traffic counts at the GSP and GWB lo-
cations (Additional file 1). Noise levels were elevated at
GSP and GWB compared to SF, although only a single
measurement of noise was taken at SF (Additional file 1).
There was a trend of increasing pollution levels, with
SF exhibiting the lowest and GWB exhibiting the highest
average concentrations, for PM mass and carbonaceous
Table 2 Pre-exposure values of biological endpoints
SF GSP GWB P-value
Subjects (n) Mean (range) Mean (range) Mean (range)
Respiratory measurements
eNO (ppb) 19 22 (8–66) 24 (9–61) 19 (9–50) 0.14
FVC (L) 18 4.6 (3.3-6.8) 4.7 (3.2-6.6) 4.6 (3.3-6.5) 0.96
FEV1 (L) 18 3.8 (2.7-6.1) 3.7 (2.6-5.7) 3.8 (2.7-5.9) 0.61
FEV1/FVC 18 0.8 (0.6-0.9) 0.9 (0.6-1.0) 0.8 (0.6-1.0) 0.44
Inflammatory measurements
CRP (ng/mL) 17 30.1 (1.3-93.9) 31.6 (0.9-149.3) 53.2 (6.3-225.3) 0.01*
SAA (ng/mL) 16 32.1 (6.1-93.9) 29.8 (3.9-88.3) 66.5 (9.4-355.1) 0.08
sICAM (ng/mL) 17 4.4 (2.2-8.1) 4.5 (1.7-7.3) 5.5 (2.5-8.8) 0.01*
IL-1β (pg/mL) 21 3.7 (0.4-13.9) 3.6 (0.2-17.7) 3.0 (0.2-25.9) 0.86
IL-8 (pg/mL) 21 3.3 (0.8-15.3) 2.4 (0.0-6.7) 2.0 (0.8-5.0) 0.13
Cortisol (ng/mL) 10 0.4 (0.1-0.8) 0.4 (0.2-0.6) 0.3 (0.1-0.6) 0.21
Blood pressure measurements
SBP (mmHg) 18 126 (106–166) 124 (95–162) 129 (109–155) 0.27
DBP (mmHg) 18 82 (66–103) 82 (64–97) 79 (56–99) 0.21
PP (mmHg) 18 43 (23–70) 41 (19–65) 46 (15–63) 0.14
MAP (mmHg) 18 97 (81–124) 96 (76–119) 96 (78–118) 0.91
Heart rate variability measurements
SDNN (ms) 18 77 (34–186) 72 (28–164) 75 (43–106) 0.81
rMSSD (ms) 18 41 (15–118) 43 (13–161) 48 (18–94) 0.57
HF (ms2) 18 1048 (23–6822) 1054 (20–7261) 1106 (52–4574) 0.99
LF (ms2) 18 1651 (407–4835) 2483 (110–13518) 1599 (250–4186) 0.23
LF:HF 18 5.0 (0.5-20.6) 4.9 (0.2-13.1) 3.0 (0.3-6.6) 0.10
Heart rate (BPM) 18 77.8 (58.9-94.9) 78.9 (60.4-118.1) 78.7 (62.2-128.0) 0.94
SF Sterling Forest, GSP Garden State Parkway, GWB George Washington Bridge. Statistically significant differences in pre-exposure values were assessed using
repeated-measures ANOVA. *p-value < 0.05
Pre-exposure values expressed as mean (range) at each location
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gional pollutant, ambient O3 concentrations did not vary
between locations (p = 0.92). A correlation matrix be-
tween the measured pollutants and meteorological con-
ditions is shown in Table 4. PM2.5 EC was strongly and
positively correlated with PM10 EC and BC. PM2.5 and
PM10 were weakly associated with the other pollutants.
The mean SO2, NO, NO2, CO, and O3 concentrations
collected from the portable instrument were near or
below the instrument’s detection limit.
Health effects associated with air pollutant measurements
Health effects were assessed both using a site-by-site
comparison and a mixed effect model for pollution and
location. When analyzed on a site-by-site basis (Fig. 1),
lung function measurements did not differ between loca-
tions (Additional file 2). However, an approximate 5 %
increase in eNO was observed at the GWB post expos-
ure, whereas all other measurements of eNO weredecreased, when compared to pre-exposure values.
However, the increase at the GWB was not statistically
significant (p = 0.13).
Post exposure increases in IL-1β were found at all
locations, with the greatest increase at GWB at 24 h post
exposure. For sICAM, CRP, and SAA, the greatest per-
cent changes were measured at SF 24 h following expo-
sures. For sICAM the decrease observed at GWB
compared to SF was statistically significant. No signifi-
cant differences in cortisol were found following expo-
sures at any location (Additional file 2). sVCAM, IL-6,
and TNF-α values were below the assay detection limits.
When assessing the influence of location on cardiovas-
cular endpoints, decreases in SBP and PP were observed
post exposure at SF, GSP, and GWB, and these decreases
were sustained at GWB 24 h following exposure. An
approximate 5 % decrease in DBP was also observed im-
mediately following all exposures, but these decreases
were not statistically significant. Decreases in the HF
Table 3 Pollutant and meteorological concentrations at each location
Overall means SF GSP GWB P-value
PM2.5 (μg/m
3) 20 13 (7–24) 21 (9–50) 31 (11–45) < 0.01
PM10 (μg/m
3) 26 16 (6–29) 26 (17–48) 38 (21–50) < 0.01
PM2.5 EC (μg/m3) 2.0 0.6 (0.0–1.7) 1.7 (0.1–3.3) 5.3 (0.1–13.2) < 0.01
PM10 EC (μg/m3) 2.6 0.9 (0.1–2.5) 2.3 (0.0–7.2) 6.6 (2.2–15.7) < 0.01
BC (μg/m3) 3.3 1.5 (0.2–3.6) 2.8 (1.3–4.1) 7.2 (4.1–10.9) < 0.01
PM2.5 OC (μg/m3) 13.9 10 (4–20) 13 (8–20) 21 (12–29) < 0.01
Ozone (ppm)a 0.05 0.04 (0.02–0.06) 0.04 (0.01–0.06) 0.04 (0.02–0.06) 0.92
Temperature (°F)b 74 71 (50–81) 75 (66.87) 75 (70–91) 0.24
Relative humidity (%)b 72 69 (47–95) 79 (56–97) 65 (49–84) 0.03
SF Sterling Forest, GSP Garden State Parkway, GWB George Washington Bridge. P-values were calculated using a 1-factor ANOVA
aHourly ozone concentrations were obtained from the US EPA Air Quality System Data Mart
bHourly relative humidity and ambient temperature measurements were obtained from New Jersey Department of Environmental Protection’s Air Quality Index Now
Values expressed as mean (range)
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exposures, and this was significantly reduced compared
to the SF and GSP locations. Increases ranging from 10-
55 % in the LF HRV metric were found following all
exposures, but these data were variable and non-
significant. Large increases in LF:HF were observed at all
locations both immediately and 24 h following expo-
sures, but these increases were fairly uniform across all
locations. No significant changes in heart rate immedi-
ately following exposures was observed at any location
(Fig. 1).
On a site-by-site basis, it appeared that the GWB elic-
ited the greatest change in the health outcomes mea-
sured. Thus, in the mixed effect model the location was
added as a fixed indicator to remove any influence of the
location on the measured health effects and only used to
assess differences in air pollutants. With the exception
of a 14.94 % (95 % CI: −0.56, 30.43) increase in blood
IL-1β levels, PM10 mass concentrations did not greatly
(i.e., greater or less than 5 %) contribute to changes in
any of the health outcomes measured (Additional file 3).Table 4 Pearson's Correlation Coefficients between air pollutant me
PM2.5 PM10 PM2.5 EC PM10
PM2.5
PM10 0.66
PM2.5 EC 0.29 0.47
PM10 EC 0.23 0.44 0.93
BC 0.38 0.63 0.88 0.84
PM2.5 OC 0.40 0.59 0.54 0.46
O3 0.39 0.28 −0.20 −0.3
Temp 0.47 0.50 −0.10 −0.1
RH −0.38 −0.08 −0.05 0.00
EC Elemental carbon, BC Black carbon, OC Organic carbon
Values represent correlation coefficients at all the locations combinedAdditionally, as PM2.5 EC was strongly and positively
correlated with both PM10 EC and BC, and the direc-
tion and magnitude of changes were similar between
the pollutants, the results of associations between
health measurements and PM10 EC and BC, along
with O3, can be found in the Supplemental Material
(Additional file 3) and the results of the mixed effect
model for PM2.5, PM2.5 EC, and PM2.5 OC can be seen in
Table 5.
PM2.5, PM2.5 EC, and PM2.5 OC mass concentrations
had very minimal associations with changes in respira-
tory measurements, and only modest (~2 %) decreases
in eNO were observed with increasing levels of PM2.5
OC, although this was not statistically significant
(Table 5). Therefore, any effect found solely on a site-by-
site basis for eNO was lost using our mixed effect
model. In addition, minimal changes in CRP, sICAM,
and IL-8 were observed, and statistically significant 5-
8 % decreases in SAA at 24 h following exposures were
observed with increasing PM2.5, PM2.5 EC, and PM2.5
OC concentrations. Increases in IL-1β were found withasurements and meteorological measurements
EC BC PM2.5 OC O3 Temp
0.60
1 0.12 0.28
3 0.14 0.25 0.26
−0.18 0.13 −0.32 −0.08
Fig. 1 Percent changes in a eNO, b IL-1 β, c ICAM, d SBP, e PP, f HF, g LF:HF, h HR at SF, GSP, and GWB for post- and 24 h measurements,
compared to pre-exposure measurements. Health outcomes were analyzed using a repeated-measures ANOVA to assess statistical significance
between locations, followed by a Student Newman-Keul’s post hoc test. Values represent mean ± SE. *p value < 0.05
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sults obtained looking at changes in IL-1β on a site-by-
site basis, and this was significant for PM2.5 EC 24 h
post-exposure. A trend of decreasing cortisol was ob-
served, but this was not statistically significant.In looking at the effect of traffic PM components on
BP measurements, small negative effects (i.e., changes
less than 2 %) were observed for SBP, DBP, and MAP
(Table 5), similar to those observed when assessing the
results solely based on location (Fig. 1). The largest
Table 5 Slopes (95 % Confidence Intervals) from mixed-effect modelsa between percent changes in health effects and pollutants
PM2.5 PM2.5 EC PM2.5 OC PM2.5 PM2.5 EC PM2.5 OC
Post 24 h
Respiratory measurements
eNO -0.38 (-1.06,0.31) -1.37 (-3.99.1.25) -2.08 (-3.70,-0.46) 0.87 (-0.09,1.82) -0.14 (-4.03,3.74) -2.14 (-4.49,0.21)
Inflammatory measurements
CRP 0.32 (-1.37,2.01) 1.17 (-5.42,7.75) -0.29 (-4.41,3.83) -1.87 (-4.37,0.64) -4.97 (-14.82,4.88) -0.44 (-6.57,5.69)
SAA -0.29 (-1.57,0.99) -1.15 (-6.00,3.70) -0.90 (-4.06,2.26) -2.59 (-4.53,-0.64) -8.03 (-15.55,-0.52) -5.47 (-10.23,-0.72)
sICAM -0.44 (-1.80,0.92) -0.98 (-6.06,4.09) -1.13 (-4.41,2.14) -1.21 (-2.52,0.09) -0.74 (-5.85,4.37) -2.13 (-5.43,1.17)
IL-1β 2.66 (-2.29,7.60) 2.32 (-17.15,21.79) 4.38 (-16.15,7.40) 3.82 (-8.12,15.76) 55.09 (10.91,99.27) -2.23 (-31.45,26.99)
IL-8 0.37 (-0.77,1.52) -3.80 (-8.21,0.62) -1.23 (-3.93,1.48) 0.47 (-1.09,2.02) -1.26 (-7.45,4.92) -1.92 (-5.71,1.87)
Cortisol -0.37 (-2.02,1.28) -0.35 (-6.88,6.18) 1.94 (-1.85,5.72) -1.06 (-4.18,2.05) -12.56 (-25.64,0.51) 4.80 (-2.34,11.94)
Blood pressure measurements
SBP -0.04 (-0.31,0.24) -1.65 (-2.62,-0.68) -0.06 (-0.72,0.59) -0.17 (-0.48,0.14) -1.70 (-2.81,-0.58) -0.28 (-1.02,0.47)
DBP -0.11 (-0.41,0.19) -0.74 (-1.88,0.40) 0.33 (-1.05,0.39) -0.25 (-0.67,0.18) -1.02 (-2.65,0.61) -0.82 (-1.86,0.22)
PP 0.04 (-0.80,0.89) -4.43 (-7.53,-1.32) 0.28 (-1.73,2.29) -0.30 (-1.17,0.58) -3.99 (-7.77,-0.70) 0.69 (-1.40,2.78)
MAP -0.07 (-0.32,0.17) -1.11 (-2.00,-0.22) -0.20 (-0.78,0.38) -0.20 (-0.50,0.11) -1.28 (-2.43,-0.14) -0.56 (-1.31,0.18)
Heart rate variability measurements
SDNN 0.09 (-0.83,1.01) 0.15 (-3.26,3.57) 0.00 (-2.07,2.07) -0.39 (-1.28,0.51) -0.90 (-4.34,2.55) 0.70 (-1.27,2.68)
rMSSD -0.03 (-0.89,0.82) -1.86 (-4.99,1.28) -0.17 (-2.07,1.73) -0.82 (-1.82,0.18) -4.35 (-7.89,-0.81) 0.02 (-2.26,2.30)
HF 0.13 (-2.01,2.27) 0.04 (-7.86,7.94) 4.57 (-0.04,9.18) -0.05 (-3.77,3.67) -7.57 (-21.92,6.78) -0.38 (-8.50,7.74)
LF -0.84 (-4.88,3.20) -3.22 (-19.10,12.66) -0.31 (-9.17,8.56) 0.63 (-2.55,3.81) 6.67 (-5.66,18.99) -0.24 (-7.19,6.71)
LF:HF 2.09 (-11.63,15.81) 24.47 (0.93,48.00) 1.15 (-12.55,14.84) 1.99 (-15.39,19.36) 26.71 (3.82,49.60) 4.73 (-9.13,18.59)
Heart rate -0.01 (-0.36,0.34) 0.65 (-0.59,1.88) 0.14 (-0.61,0.90) 0.16 (-0.25,0.57) 1.63 (0.25,3.00) -0.46 (-1.36,0.45)
aThe mixed effect model adjusted for apparent temperature, location, and random subject effects
Percent change was calculated between the pre-exposure measurement and each subsequent measurement (i.e. post or 24 hrs post)
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PM2.5, PM2.5 EC, and PM2.5 OC measurements and PP
24 h after exposure. When assessing associations be-
tween pollutants and measures of HRV, decreases in the
root mean squared of successive deviations in NN inter-
vals (rMSSD) were observed, with the greatest reduction
(4.4 % decrease) associated with PM2.5 EC (Table 5). In-
creases in HF were found immediately following expo-
sures, yet decreases in HF were observed 24 h after
exposures; the magnitude of these changes was minimal
with the exception of a 7.6 % decrease with PM2.5 EC.
The LF:HF was positively associated with the measured
pollutants both immediately after and 24 h following
exposures.
Sensitivity analyses were conducted by removing 2
subjects with a body mass index (BMI) > 39, 2 subjects
with a past history of asthma, and 1 subject that re-
ported anxiety during an exposure. No significant
changes in the group mean results were observed with
the removal of the past asthmatic and anxious subjects;
however, it appeared that the exclusion of the 2 obese
subjects reduced the associations observed betweenPM2.5 EC and BP, HRV, and cytokine measurements
(Additional file 4).
Discussion
In the healthy participants in this study, acute exposures
to traffic pollutants elicited cardiovascular and inflam-
matory changes that were most strongly associated with
PM2.5 EC and OC. This present study is unique in its
use of multiple locations and diverse outcomes mea-
sured. We also describe a novel application of a blood
collection technique suitable for field use. We collected
PM and gaseous concentrations using a custom-built,
high-volume mobile sampling platform [17]. The design
of the platform allowed us to collect sufficient PM to re-
liably obtain filter weights and EC/OC concentrations in
a relatively short sampling period. In this study, we ob-
served elevated PM2.5 and PM10 at the GWB compared
to GSP; the increased number of diesel-fueled engines at
the GWB likely contributed to the difference in PM con-
centrations [23]. We also observed elevated EC, BC, and
OC concentrations at GSP compared to SF. Although
the GSP cars-only location was picked with the intent of
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hicles, reports have suggested that the contribution of
BC from gasoline exhaust may be underestimated [24].
In addition to PM, a small group of traffic-associated
gases were measured during exposures; however, these
concentrations rarely exceeded the limit of detection,
and could not be used reliably for analysis. Regional O3,
however, was included in the model and was not associ-
ated with any measured health outcomes as part of this
work. As this work focused on microenvironmental ex-
posures to traffic pollutants, ambient NO2 concentra-
tions measured at central monitors were not explored,
particularly as NO2 has been shown to be elevated near
roadways and then decline to background levels after
100–500 m [25, 26]. However, we cannot rule out
the possibility that changes in health measurements
could be associated, in part, to NO2 or other gaseous
pollutants.
In the mixed effects model, we found slight decreases
in eNO with increasing concentrations of PM2.5 OC and
EC. However, when eNO was analyzed on a site-by-site
basis, eNO decreased at GSP and SF, whereas a 5 % in-
crease was found at the GWB immediately following ex-
posures. Although this increase in eNO at the GWB was
not statistically significant, in previous studies, such in-
creases in eNO have been associated with benzene [27],
particle number [28], soot [28], ultrafine particles [29],
and carbon monoxide [30].
Various hypotheses have been proposed to explain the
interaction between exposure to PM and systemic in-
flammation. One hypothesis suggests that inhaled PM
can induce a local inflammatory response in the pul-
monary system. According to another hypothesis, PM
penetrates into the vascular system directly, interacting
with endothelial cells that release cytokines into the
blood [31, 32]. It has also been speculated that airway
injury due to the inhalation of air pollutants can increase
levels of IL-6 and IL-8, activating mononuclear and
endothelial cells which further initiate the secretion of
acute-phase proteins and cellular adhesion molecules
[33]. In testing these ideas, we did not detect, with the
exception of statistically significant increased levels of
IL-1β, systemic inflammatory responses. A few studies
have assessed IL-1β in the blood of human participants
following ambient pollution exposures, and found in-
creases in IL-1β associated with PM10 [31], ambient air
pollution [34], and diesel [32]. For the remaining serum
proteins, results were inconsistent among studies as to
whether increases or decreases in proteins were ob-
served [34–39]. These inconsistent results could be re-
lated to the study populations or the time points used.
In the current study we used a novel application of
DBS to assess changes in pro-inflammatory genes in a
field setting. There are several advantages to thistechnique. First, the use of DBS decreases the risks asso-
ciated with the use and disposal of needles and syringes
for the collector, as well as only requiring a small
amount of blood for the analysis, making it attractive to
the subject as well [15, 40]. Further, past work looking at
the utility of DBS has found the same level of precision
and reproducibility as vacuum tubes and capillary pi-
pettes [16], and DBS are considered a Food and Drug
Administration registered in vitro class 11 medical de-
vice. Due to its utility and relatively inexpensive nature
for large epidemiological studies, DBS analysis has
already been used for measuring therapeutic drugs and
drugs of abuse, management of viral disease, quantifica-
tion of environmental contaminants (i.e. trace metals),
and neonatal screening programs [41–45]. Therefore, we
believe that this technique could be of high value to fu-
ture researchers involved in field studies that still wish
to look at biomarkers in the blood of their subjects.
One of the interesting findings related to this work in-
cluded small but negative associations between traffic-
related air pollutants and measurements of BP. This was
in contrast to the results presented in many previously
conducted studies [46–48]. However, decreases in BP
measurements were observed both in the site-by-site
comparison as well as the mixed effect model analyses.
For the HRV analysis, our findings were consistent with
past studies that identified associations between in-
creases in LF:HF, and the inhalation of EC [49] and BC
[50]. It is interesting that large and statistically signifi-
cant positive associations were found with LF:HF, par-
ticularly with PM2.5 EC, although small and sometimes
negative associations were found for LF and HF separ-
ately in our study. It should be noted that the range in
the LF and HF measurements was very large, which
could contribute to this discrepancy. It is also interesting
that the LF:HF, which has generally been associated with
sympathetic modulation, was found to be increased yet
BP measurements were decreased after exposure. Ac-
cording to Billman, the LF:HF can vary based on factors
other than sympathetic nerve activation, such as the
mechanical effects of respiration and prevailing heart
rate. Additionally, the sympathetic and parasympathetic
nervous system are not linearly related, which could
disrupt their balance. Therefore, LF:HF might not solely
reflect sympatho-vagal balance, which could account for
an increase in LF:HF yet a decrease in BP [51]. In our
work, decreases in rMSSD were observed 24 h following
exposures, and these decreases were associated with in-
creasing PM2.5 EC. rMSSD is a short-term measure of
vagal tone [52], and the observed decrease is consistent
with other published work of EC [53], OC [53], and
PM2.5 [50, 54]. Thus, the current study supports re-
sults in the literature regarding traffic-related pollut-
ants and their impact on HRV endpoints, but the BP
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previously published work.
In carrying out this study, it became apparent that the
GWB location could have contributed to additional
stress leading to adverse cardiovascular events, particu-
larly from higher levels of noise [55, 56]. The noise levels
were elevated at the GWB and GSP locations compared
to SF, but these noise measurements were limited and
we therefore did not control for noise in our models or
perform statistical tests. We did, however, control for
location in our model, which should have alleviated any
noise-related influences between locations. Other inves-
tigators have suggested that cortisol could serve as an
adequate marker of noise-related stress [57], and there-
fore we measured cortisol levels in peripheral blood. In
the study cohort from the first summer, no significant
differences in cortisol levels were found among the 3
study sites; due to blood sample limitations, cortisol
concentrations were not measured from the participants
for the second summer.
In the current study, multiple sensitivity analyses were
required, especially with a relatively small sample size. It
appeared that the exclusion of subjects that were anx-
ious or had a previous history of asthma did not have a
large impact on our results, whereas the exclusion of 2
obese subjects affected many of the observed effects,
suggesting that subjects with an elevated BMI might be
able to modulate the cardiovascular and immune re-
sponses. Although the number of obese subjects in this
study was small, a recent review puts forth the notion
that obesity can influence susceptibility to air pollution-
induced cardiovascular health effects [58].
Several limitations to this work exist. First, although
we calculated the distance each subject traveled to each
location and found no significant differences, we were
unable to control for ambient exposures during trans-
port to study sites or for any possible additional pollu-
tant exposures between the post- and 24 h-health
measurements. However, pre-exposure biological mea-
surements for each subject were taken at each location,
which should have controlled for any pre-exposure ef-
fects, and 24 h measurements were taken near the home
or workplace of each subject in an attempt to alleviate
additional traffic exposures. Also, in this work we did
not determine exercise load or ventilation rates and
therefore could not calculate the dose of pollutants each
participant inhaled. Locations, however, were selected
that were on fairly level ground to prevent changes in
exertion, the walking pace was controlled with no sig-
nificant difference found between locations (Additional
file 1), and we measured the HR of each subject before
and after each exposure and observed minimal changes.
In this work we also observed a large variability in the
pre-exposure protein concentrations between subjects,which could be a result of obtaining only singlet samples
at each time point; as we still found significant induc-
tions, we assume the singlet measurements were ad-
equate. It is also possible that the small sample size
limited our ability to see changes in the selected health
endpoints. Lastly, it is possible that, due to the large
number of statistical tests run, some statistically signifi-
cant associations may have occurred by chance.
Strengths of this study include microenvironmental
monitoring of air pollutants, which has proven to be op-
timal for studying pollutant-induced health effects,
thereby limiting exposure measurement error. The novel
application of DBS to air pollution field studies, which
are easy to collect, minimally invasive, easy to transport,
and useful for sampling in remote areas shows great
potential for future work. Lastly, the use of a random-
ized crossover study design allowed for each subject to
act as their own control thereby reducing within-subject
covariates.Conclusions
In conclusion, we have shown that in our study popula-
tion of 23 subjects, acute physiological and biological
changes can occur in a healthy population following a
2 h walking exposure to near-walkway traffic. Associa-
tions were found between increases in markers of in-
flammation in the blood and decreases in heart rate
variability with increasing concentrations of EC. Overall,
acute changes in cardiovascular measurements and
markers of inflammation in the blood were observed in
healthy adults exposed to traffic-related pollution.Additional files
Additional file 1: Additionally measured exposure metrics at each
location. Values represent means ± SD. Traffic volume data for the GSP
were obtained for the Essex Toll Plaza using the New Jersey Turnpike
Authority’s Open Public Records Act. Traffic volume data at the GWB
were obtained for the GWB upper level and Palisades Interstate Parkway
toll records from the PANYNJ. No traffic was observed at SF, as verified
by study staff during exposures. SF = Sterling Forest; GSP = Garden State
Parkway; GWB= George Washington Bridge. N/A = not applicable. aUnpaired
t-test. bOnly a single measurement of noise was made at SF. Noise levels at
SF without sampler on were below detection limit for instrument
(dB < 60).
Additional file 2: Percent changes in A) FVC, B) FEV1, C) FEV1/FVC,
D) CRP, E) SAA, F) IL-8, G) DBP, H) MAP, I) SDNN, J) rMSSD, K) LF,
and L) cortisol at SF, GSP, and GWB for post- and 24 h measurements,
compared to pre-exposure measurements. Health outcomes were
analyzed using a repeated-measures ANOVA to assess statistical significance
between locations, followed by a Student Newman-Keul’s post hoc
test. Values represent mean ± SE. *p value < 0.05.
Additional file 3: Slopes (95 % Confidence Intervals) generated
from mixed effect models between percent changes in pollutant
concentrations and health effects for the subjects, adjusting for
apparent temperature, location, and random subject effects. Percent
change were calculated between the pre-exposure measurement and
each subsequent measurement (i.e. post or 24 h post).
Mirowsky et al. Environmental Health  (2015) 14:66 Page 11 of 12Additional file 4: Slopes (95 % Confidence Intervals) generated
from mixed effect models between percent changes in pollutant
concentrations and health effects for the subjects, adjusting for
apparent temperature, location, and random subject effects.
Analysis was completed removing 2 subject that presented with
BMI > 39. Percent change were calculated between the pre-exposure
measurement and each subsequent measurement (i.e. post or 24 h post).
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